Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $108.68 billion. The enterprise value is $128.43 billion.
Market Cap | 108.68B |
Enterprise Value | 128.43B |
Important Dates
The last earnings date was Tuesday, November 19, 2024, before market open.
Earnings Date | Nov 19, 2024 |
Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -1.69% in one year.
Current Share Class | 1.28B |
Shares Outstanding | 1.28B |
Shares Change (YoY) | -1.69% |
Shares Change (QoQ) | -0.74% |
Owned by Insiders (%) | 0.05% |
Owned by Institutions (%) | 85.54% |
Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 25.94 and the forward PE ratio is 14.87. Medtronic's PEG ratio is 2.64.
PE Ratio | 25.94 |
Forward PE | 14.87 |
PS Ratio | 3.33 |
Forward PS | 3.18 |
PB Ratio | 2.22 |
P/TBV Ratio | n/a |
P/FCF Ratio | 19.74 |
P/OCF Ratio | 15.09 |
PEG Ratio | 2.64 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.88, with an EV/FCF ratio of 23.35.
EV / Earnings | 29.95 |
EV / Sales | 3.89 |
EV / EBITDA | 13.88 |
EV / EBIT | 19.43 |
EV / FCF | 23.35 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.58.
Current Ratio | 1.84 |
Quick Ratio | 1.17 |
Debt / Equity | 0.58 |
Debt / EBITDA | 2.97 |
Debt / FCF | 5.15 |
Interest Coverage | 8.63 |
Financial Efficiency
Return on equity (ROE) is 8.61% and return on invested capital (ROIC) is 5.37%.
Return on Equity (ROE) | 8.61% |
Return on Assets (ROA) | 4.59% |
Return on Capital (ROIC) | 5.37% |
Revenue Per Employee | $347,326 |
Profits Per Employee | $45,137 |
Employee Count | 95,000 |
Asset Turnover | 0.37 |
Inventory Turnover | 2.03 |
Taxes
In the past 12 months, Medtronic has paid $831.00 million in taxes.
Income Tax | 831.00M |
Effective Tax Rate | 16.12% |
Stock Price Statistics
The stock price has increased by +12.63% in the last 52 weeks. The beta is 0.85, so Medtronic's price volatility has been lower than the market average.
Beta (5Y) | 0.85 |
52-Week Price Change | +12.63% |
50-Day Moving Average | 89.07 |
200-Day Moving Average | 84.45 |
Relative Strength Index (RSI) | 34.66 |
Average Volume (20 Days) | 6,618,529 |
Short Selling Information
The latest short interest is 10.18 million, so 0.79% of the outstanding shares have been sold short.
Short Interest | 10.18M |
Short Previous Month | 10.67M |
Short % of Shares Out | 0.79% |
Short % of Float | 0.79% |
Short Ratio (days to cover) | 2.19 |
Income Statement
In the last 12 months, Medtronic had revenue of $33.00 billion and earned $4.29 billion in profits. Earnings per share was $3.27.
Revenue | 33.00B |
Gross Profit | 21.58B |
Operating Income | 6.61B |
Pretax Income | 4.81B |
Net Income | 4.29B |
EBITDA | 9.25B |
EBIT | 6.61B |
Earnings Per Share (EPS) | $3.27 |
Balance Sheet
The company has $7.99 billion in cash and $28.33 billion in debt, giving a net cash position of -$20.34 billion or -$15.86 per share.
Cash & Cash Equivalents | 7.99B |
Total Debt | 28.33B |
Net Cash | -20.34B |
Net Cash Per Share | -$15.86 |
Equity (Book Value) | 48.72B |
Book Value Per Share | 37.81 |
Working Capital | 10.24B |
Cash Flow
In the last 12 months, operating cash flow was $7.20 billion and capital expenditures -$1.70 billion, giving a free cash flow of $5.50 billion.
Operating Cash Flow | 7.20B |
Capital Expenditures | -1.70B |
Free Cash Flow | 5.50B |
FCF Per Share | $4.29 |
Margins
Gross margin is 65.41%, with operating and profit margins of 20.04% and 13.00%.
Gross Margin | 65.41% |
Operating Margin | 20.04% |
Pretax Margin | 15.62% |
Profit Margin | 13.00% |
EBITDA Margin | 28.04% |
EBIT Margin | 20.04% |
FCF Margin | 16.07% |
Dividends & Yields
This stock pays an annual dividend of $2.80, which amounts to a dividend yield of 3.30%.
Dividend Per Share | $2.80 |
Dividend Yield | 3.30% |
Dividend Growth (YoY) | 1.46% |
Years of Dividend Growth | 48 |
Payout Ratio | 85.73% |
Buyback Yield | 1.69% |
Shareholder Yield | 5.00% |
Earnings Yield | 3.95% |
FCF Yield | 5.07% |
Analyst Forecast
The average price target for Medtronic is $93.94, which is 10.86% higher than the current price. The consensus rating is "Hold".
Price Target | $93.94 |
Price Target Difference | 10.86% |
Analyst Consensus | Hold |
Analyst Count | 17 |
Revenue Growth Forecast (5Y) | 4.85% |
EPS Growth Forecast (5Y) | 22.00% |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
Last Split Date | Sep 27, 1999 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.81 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.81 |
Piotroski F-Score | 5 |